文献速递临床试验与 GCP

「醒脑开窍」皮内针法治疗腹腔镜术后胃肠功能障碍的随机对照试验研究方案

Efficacy and safety of the "Xingnao Kaiqiao" acupuncture technique via intradermal needling to treat postoperative gastrointestinal dysfunction of laparoscopic surgery: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-11-28

本研究为单中心、双盲、随机对照试验方案,拟纳入天津南开医院微创外科拟行腹腔镜手术的住院患者,随机分为「醒脑开窍」组与假刺激组,术后6小时起每12小时皮内针刺激内关、人中、三阴交,共6次,评价首次排气时间等指标。

要点

  • 方案为单中心、双盲、随机对照试验,遵循CONSORT 2010与STRICTA。
  • 干预为术后6小时起每12小时皮内针刺激内关、人中、三阴交,共6次,每次3分钟。
  • 主要结局为术后首次排气时间。

核心结论

  • 该随机对照试验旨在为「醒脑开窍」皮内针法治疗腹腔镜术后胃肠功能障碍提供疗效与安全性证据,以改进该技术的临床应用。

研究设计与样本

  • 单中心、双盲、随机对照临床试验,依据CONSORT 2010与STRICTA设计。
  • 受试者来自中国天津南开医院微创外科拟行腹腔镜手术的住院患者。
  • 采用SPSS 19.0生成的随机数将受试者分配至「醒脑开窍」组或假刺激组,由专门指定的研究者负责随机化。

关键数值与推荐

  • 干预于腹腔镜术后6小时开始,此后每12小时一次,共6次,每次持续3分钟。
  • 首次评估在首次治疗前(术后6小时)进行,此后每12小时重复一次,共完成7次评估。
  • 主要结局为术后首次排气时间。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Xingnao Kaiqiao acupuncture involves needling of the Neiguan (PC6), Renzhong (DU26), and Sanyinjiao (SP6) acupoints. The technique has a significant clinical effect in many neurological diseases. In the present report, we have developed a protocol for a scientific trial to analyze whether Xingnao Kaiqiao can be used to treat gastrointestinal dysfunction after laparoscopic surgery. In this context, we intend to execute a double-blind, randomized controlled trial to assess the efficacy and safety of Xingnao Kaiqiao acupuncture via intradermal needling. METHODS/DESIGN: This will be a single-center, double-blind, randomized controlled clinical trial. It has been designed on the basis of the Consolidated Standards of Reporting Trials (CONSORT 2010) guidelines and the Standards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA). The subjects will be recruited from among inpatients scheduled for laparoscopic surgery at the Department of Minimally Invasive Surgery, Tianjin Nankai Hospital, Tianjin, China. Using random numbers generated in SPSS 19.0, the recruited subjects will be allocated to either the "Xingnao Kaiqiao" group or the sham stimulation group. A specially appointed investigator will be in charge of the randomization. Xingnao Kaiqiao via intradermal needling (or sham needling) will be administered 6 h after laparoscopic surgery, and then every 12 h for a total of six sessions, each of which will last 3 min. The subjects will undergo their first evaluation shortly before the first treatment (6 h after laparoscopic surgery); evaluations will be repeated every 12 h until a total of seven evaluations have been completed. The primary outcome will be the time until the first postoperative flatus. The secondary outcomes will be: the time until the first postoperative defecation; levels of abdominal pain, abdominal distension, and nausea; blood ghrelin level; occurrence of vomiting; psychological status; and quality of life. DISCUSSION: This upcoming randomized clinical trial was designed as a standardized method to assess the efficacy and safety of Xingnao Kaiqiao acupuncture using intradermal needles on PC6, DU26, and SP6 in the treatment of gastrointestinal dysfunction after laparoscopic surgery. We aim to provide evidence and thus improve the clinical application of this technique. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR-IOR-17010763 . Registered on 2 March 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhao W, Li J, Wang Y, et al. Efficacy and safety of the "Xingnao Kaiqiao" acupuncture technique via intradermal needling to treat postoperative gastrointestinal dysfunction of laparoscopic surgery: study protocol for a randomized controlled trial. Trials. 2017. PMID: 29179761. doi:10.1186/s13063-017-2319-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。